Medical
J&J Gets FDA Warning About Handling Of Complaints
May 31, 2012 9:18 am | News | CommentsThe FDA says a J&J unit received 227 complaints about various products and most often closed them without a thorough investigation.
Senate Bill Aims To Increase Drug Import Safety
May 25, 2012 9:24 am | by Matthew Perrone, AP Health Writer | News | CommentsU.S. regulators would inspect more drug manufacturing facilities in China, India and other foreign countries in order to ensure quality.
Boston Scientific Gets Approval For New Leg Stent
May 18, 2012 9:09 am | News | CommentsMedical device maker Boston Scientific Corp. said it received U.S. approval for a new type of stent to treat blocked arteries in the legs.
Agilent Buying Dako For $2.2B
May 17, 2012 9:03 am | News | CommentsAgilent Technologies Inc. said it is buying the cancer diagnostic company to help it develop a wider range of cancer-fighting products.
Medtronic: Bone Graft Investigation Is Over
May 16, 2012 9:39 pm | News | CommentsMedical device maker Medtronic Inc. said Wednesday that federal prosecutors have closed their investigation of the company's InFuse bone graft.
CryoLife Buying Vascular Graft Maker For $17M
May 15, 2012 9:50 pm | News | CommentsMedical device maker has agreed to buy Hemosphere Inc., which makes a vascular graft that is used in kidney dialysis patients, for $17 million in cash.
Alere Skids On Expected Recall, Federal Subpoena
May 11, 2012 2:23 pm | News | CommentsShares of the medical diagnostics company slipped after it announced that the government was concerned over its marketing and quality-control testing.
Seven Success Criteria For Hiring A GMP Consultant
May 11, 2012 1:33 pm | by The QA Pharm | Blogs | CommentsThere is nothing worse than throwing a bunch of consultants at a problem without knowing the boundaries of the project or defining the expected results. Unfortunately, it happens all the time. It ends in frustration for all parties involved. A formal scope of work (SOW) helps both the client and the consultant to set expectations of each other, and agree on basic assumptions that are critical to success.
Omnicare Pays $50 Million To Settle DOJ Case
May 11, 2012 12:52 pm | News | CommentsThe company said there were no allegations that drugs were illegally diverted to someone without prescriptions and no patients were harmed.
Two Molecular Biologists Get $500K Medical Prize
May 11, 2012 9:29 am | News | CommentsThe two men performed pioneering research on how cells express their genetic information at The Rockefeller University in New York City.
Company Recalls Nebraska Lethal Injection Drug
May 10, 2012 9:24 am | by Grant Schulte, Associated Press | News | CommentsNaari AG asked Nebraska officials to quarantine its supply of sodium thiopental because it was "illegally diverted" from its supply chain.
China To Reinvestigate Human Flesh Capsule Claims
May 8, 2012 9:18 am | News | CommentsSouth Korean officials say they seized smuggled capsules containing powdered remains of dead babies, which some believe can cure a variety of diseases.
Abbott Labs Settles $1.5B Dispute Over Drug Claims
May 7, 2012 1:03 pm | by Pete Yost, Associated Press | News | CommentsAttorneys general from across the country alleged that Abbott marketed its anti-seizure drug Depakote for unapproved uses.
Contract Manufacturing And Recalls
May 7, 2012 12:18 pm | by Mike Rozembajgier, Vice President of Recalls, StericycleExpertRECALL | Articles | CommentsPharmaceutical companies face increased competition to meet consumer demand, which means tighter and more complex deals with contract manufacturers.
NIH, Companies Aim To Teach Old Drugs New Tricks
May 3, 2012 2:08 pm | by Lauran Neergaard, AP Medical Writer | News | CommentsPfizer, AstraZeneca and Eli Lilly & Co. are dusting off two dozen old drugs that failed to treat one disease but might treat another.
Impax Labs Falls On Weak Sales, New FDA Warning
May 2, 2012 9:27 am | News | CommentsThe FDA recently issued a Form 483, which said inspectors found problems in Impax's quality control laboratory.
US Approves Antibiotic To Treat, Prevent Plague
April 30, 2012 9:38 am | by the Associated Press | News | CommentsThe Johnson & Johnson antibiotic is able to cure a vast majority of the rare bacterial infections, which could be use as a potential bioterrorism agent.
Hologic Buying Gen-Probe For About $3.72B
April 30, 2012 8:47 am | News | CommentsMedical device maker Hologic Inc. said Monday that it will buy diagnostic test maker Gen-Probe for about $3.72 billion in an all-cash deal.
Novo Nordisk To Expand U.S. Workforce By 15 Pct.
April 27, 2012 2:18 pm | News | CommentsThe company will look to fill positions at its new type 1 diabetes research center in Seattle and at a manufacturing plant in North Carolina.
New J&J CEO Plans Realistic, Optimistic Future
April 26, 2012 9:23 am | by Linda A. Johnson, AP Business Writer | News | CommentsNew CEO Alex Gorsky said one of his short-term priorities is to get "reliable" consumer products back on store shelves.
Alabama Restricts Cold Medicines To Stop Meth
April 20, 2012 2:00 pm | by Phillip Rawls, Associated Press | News | CommentsThe bill is the latest in recent years to try to slow down meth production, which uses cold and allergy medicine containing ephedrine or pseudoephedrine.
Does Giving Antibiotics To Animals Hurt Humans?
April 20, 2012 1:45 pm | by Matthew Perrone, AP Health Writer | News | CommentsAntibiotics have saved countless lives in treating a variety of diseases, but some argue their use in meat breeds antibiotic-resistant germs.
Medical Firm To Build Plasma Plant In Georgia
April 19, 2012 9:35 am | by Errin Haines, Associated Press | News | CommentsBaxter International Inc. will employ about 1,500 people to make plasma-based therapies that treat chronic and life-threatening illnesses.
EU Clears J&J's $21.3BN Synthes Acquisition
April 19, 2012 8:31 am | News | CommentsThe European Union's competition regulator says it has approved Johnson & Johnson's $21.3 billion acquisition of Swiss orthopedics maker Synthes.
High Court Weighs Overtime Pay For Drug Sales Reps
April 17, 2012 9:38 am | by Mark Sherman, Associated Press | News | CommentsThe justices questioned whether the federal law governing overtime pay should apply to those who try to persuade doctors to prescribe certain drugs.
